Unknown

Dataset Information

0

Haemanthus coccineus extract and its main bioactive component narciclasine display profound anti-inflammatory activities in vitro and in vivo.


ABSTRACT: Haemanthus coccineus extracts (HCE) have traditionally been used to treat a variety of diseases, like febrile colds or asthma. Since new therapeutic options against inflammatory processes are still urgently needed, we aimed to pharmacologically characterise the anti-inflammatory potential of HCEin vitro and in vivo and to identify the underlying bioactive component(s). The action of HCE on oedema formation and leucocyte infiltration were analysed in two murine models of inflammation (dermal oedema induced by arachidonic acid and croton oil; kidney injury caused by unilateral ureteral obstruction). The interaction of leucocytes with endothelial cells (ECs) as well as the activation parameters of these two cell types were analysed. Moreover, the nuclear factor ?B (NF?B) pathway was investigated in detail in ECs. Using different fractions of HCE, the bioactive principle was identified. In vivo, HCE (450 mg/kg orally or 2 mg/kg intraperitoneally) inhibited oedema formation, leucocyte infiltration and cytokine synthesis. In vitro, HCE (100-300 ng/ml) blocked leucocyte-EC interaction as well as the activation of isolated leucocytes (cytokine synthesis and proliferation) and of primary ECs (adhesion molecule expression). HCE suppressed NF?B-dependent gene transcription in the endothelium, but did not interfere with the NF?B activation cascade (I?B degradation, p65 nuclear translocation and NF?B DNA-binding activity). The alkaloid narciclasine was elucidated as the bioactive compound responsible for the anti-inflammatory action of HCE. Our study highlights HCE and its main alkaloid narciclasine as novel interesting approach for the treatment of inflammation-related disorders.

SUBMITTER: Fuchs S 

PROVIDER: S-EPMC4420604 | biostudies-literature | 2015 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Haemanthus coccineus extract and its main bioactive component narciclasine display profound anti-inflammatory activities in vitro and in vivo.

Fuchs Simone S   Hsieh Louise T LT   Saarberg Werner W   Erdelmeier Clemens A J CA   Wichelhaus Thomas A TA   Schaefer Liliana L   Koch Egon E   Fürst Robert R  

Journal of cellular and molecular medicine 20150305 5


Haemanthus coccineus extracts (HCE) have traditionally been used to treat a variety of diseases, like febrile colds or asthma. Since new therapeutic options against inflammatory processes are still urgently needed, we aimed to pharmacologically characterise the anti-inflammatory potential of HCEin vitro and in vivo and to identify the underlying bioactive component(s). The action of HCE on oedema formation and leucocyte infiltration were analysed in two murine models of inflammation (dermal oede  ...[more]

Similar Datasets

| S-EPMC7961947 | biostudies-literature
| S-EPMC7772792 | biostudies-literature
| S-EPMC9311596 | biostudies-literature
| S-EPMC7466186 | biostudies-literature
| S-EPMC7109577 | biostudies-literature
| S-EPMC7083763 | biostudies-literature
| S-EPMC5362615 | biostudies-literature
| S-EPMC7692184 | biostudies-literature
| S-EPMC7374866 | biostudies-literature
| S-EPMC6236865 | biostudies-literature